Cargando…

Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance

BACKGROUND: Currently, lung adenocarcinoma is the most common form of lung cancer. Although the pathogenesis of lung adenocarcinoma is progressing rapidly, the mortality rate of lung adenocarcinoma is still high. Therefore, it is necessary to search for a new biomarker to guide the prognosis of lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Lei, Liu, Jinyuan, Xie, Jiaheng, Luo, Jinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607606/ https://www.ncbi.nlm.nih.gov/pubmed/34819749 http://dx.doi.org/10.2147/IJGM.S337615

Ejemplares similares

Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)
por: Sharlin, David S., et al.
Publicado: (2018)

Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4)
por: Ziegler, Kerstin, et al.
Publicado: (2016)

MCT8 deficiency in a patient with a novel frameshift variant in the SLC16A2 gene
por: Wakabayashi, Kei, et al.
Publicado: (2021)

Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer
por: Tao, Qingsong, et al.
Publicado: (2022)

Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter
por: Higuchi, Kei, et al.
Publicado: (2022)

Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma
por: Zhou, Heng, et al.
Publicado: (2021)

Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma
por: Zhu, Jing, et al.
Publicado: (2021)

Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma
por: Chen, Xiaoli, et al.
Publicado: (2020)

Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features
por: Ono, Erina, et al.
Publicado: (2016)

A SLC16A1 Mutation in an Infant With Ketoacidosis and Neuroimaging Assessment: Expanding the Clinical Spectrum of MCT1 Deficiency
por: Al-Khawaga, Sara, et al.
Publicado: (2019)

Histological characterization of orphan transporter MCT14 (SLC16A14) shows abundant expression in mouse CNS and kidney
por: Roshanbin, Sahar, et al.
Publicado: (2016)

Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter
por: Higuchi, Kei, et al.
Publicado: (2023)

Increased Oxidative Metabolism and Neurotransmitter Cycling in the Brain of Mice Lacking the Thyroid Hormone Transporter Slc16a2 (Mct8)
por: Rodrigues, Tiago B., et al.
Publicado: (2013)

Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
por: Puri, Sachin, et al.
Publicado: (2022)

Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021)

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
por: Stewart, Paul A., et al.
Publicado: (2015)

CPS1 expression and its prognostic significance in lung adenocarcinoma
por: Wu, Geting, et al.
Publicado: (2020)

Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma
por: Bai, Lu, et al.
Publicado: (2022)

High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021)

A pan-cancer analysis revealed the role of the SLC16 family in cancer
por: Li, Jun, et al.
Publicado: (2021)

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
por: Pertega-Gomes, Nelma, et al.
Publicado: (2015)

Untargeted metabolomics identifies the potential role of monocarboxylate transporter 6 (MCT6/SLC16A5) in lipid and amino acid metabolism pathways
por: Ren, Tianjing, et al.
Publicado: (2022)

SLC2A1 plays a significant prognostic role in lung adenocarcinoma and is associated with tumor immunity based on bioinformatics analysis
por: Wang, Yuhang, et al.
Publicado: (2022)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer
por: Markou, Athina, et al.
Publicado: (2021)

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility
por: Nakayama, Akiyoshi, et al.
Publicado: (2013)

A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma
por: Zhao, Meng, et al.
Publicado: (2023)

Prognostic and diagnostic significance of Cavin 2 in lung adenocarcinoma
por: Wang, Xianguo, et al.
Publicado: (2019)

Prognostic significance of HSF2BP in lung adenocarcinoma
por: Huang, Zhendong, et al.
Publicado: (2021)

Prognostic significance of pyroptosis-related factors in lung adenocarcinoma
por: Lin, Ximing, et al.
Publicado: (2022)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma
por: Li, Xiaowei, et al.
Publicado: (2017)

Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma
por: Xu, Feng, et al.
Publicado: (2022)

Deciphering Prognostic Value of TTN and Its Correlation With Immune Infiltration in Lung Adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2022)

Prognosis of early stage pulmonary mucinous adenocarcinoma with different treatments
por: Liu, Jinyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uh25vt49qn2rc6vt4tqak52a44